| 1Shen YC,Hsu C,Cheng AL.Molecular targeted therapy for advanced hepatocellu-lar carcinoma[J].Targ Oncol,2007,2:199-210.
2H pfner M,Schuppan D,Scherbl H.Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular[J].Cancer World J Gastroenterol,2008,14(1):1-14.
3Pang RW,Poon RT.From molecular biology to targeted therapies for hepatocellular carcinoma:the future is now[J].Oncology,2007,72(1):30-44.
4Kumar S,Witzig TE,Rajkumar SV.Thalidomide as an anti-cancer agent[J].J Cell Mol Med,2002,(6):160-174.
5Eleutherakis-Papaiakovou V,Bamias Aand Dimopoulos MA.Thalidomide in canc-er medicine[J].Annals of Oncology,2004,15:1151-60.
6Han CJ.Recent developments in systemic chemotherapy for hepatocellular carcino-ma[J].Korean J Hepatol,2008,14(1):4-11.
7Hsu C,Chen CN,Chen LT,et al.Low-dose thalidomide treatment for advanced hepatocellular carcinoma[J].Oncology,2003,65(3):242-249.
8Pang RW,Poon RT.From molecular biology to targeted therapies for hepatocellular carcinoma:the future is now[J].Oncology,2007,72(Suppl)1:30-44.
9Schwartz JD,Sung M,Schwartz M,et al.Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression[J].Oncologist,2005,10(9):718-727.
10Lin AY,Brophy N,Fisher GA,etal.Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma[J].Cancer,2005,103(1):119-25.
11Patt YZ,Hassan MM,Lozano RD,et al.Thalidomide in the treatment of patients with hepatocellular carcinoma:a phase II tria[J].Cancer,2005,103(4):749-755.
12Chiou HE,Wang TE,Wang YY,et al.Efficacy and safety of thalidomide in pa-tients with hepatocellular carcinoma[J].World J Gastroenterol2006,12(43):6955-60.
13Yau T,Chan P,WongH,etal.Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma[J].Oncology,2007,72(Suppl1):67-71.
14Chuah B,Lim R,Boyer M,et al.Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma[J].Acta Oncol,2007,46(2):234-238.
15Pinter M,Wichlas M,Schmid K,et al.Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach:a phase I/II tria[J].Eur J Gas-troenterol Hepatol,2008,20(10):1012-19.
16Han SH,Park SH,Kim JH,et al.Thalidomide for treating metastatic hepatocellu-lar carcinoma:a pilot study[J].Korean J Intern Med,2006,21(4):225-229.
17Chang JY,Ka WS,Chao TY,et al.Hepatocellular carcinoma with intra-atrial tumor thrombi.Areportof three cases responsive to thalidomide treatmentand lit-erature review[J].Oncology,2004,67(3-4):320-326.
18ZHANG ZL,LIU ZS,SUN Q.Anti-tumor effect of thalidomide and paclitaxel on hepatocellular carcinoma in nude mice[J].CMJ2005,118(20):1688-94.
19Jeong W,Chun HG,Cer D,et al.A combination of capecitabine and thalidomide in patients with hepatocellular carcinoma[J].Journal of Clinical Oncology,2006ASCO Annual Meeting Proceedings Part I.2006,24:(18S)(Suppl):4142.
20Zhu AX,Fuchs CS,Clark JW,et al.A phase II study of epirubicin and thalido-mide in unresectable or metastatic hepatocellular carcinoma[J].Oncologist,2006,11(1):87-88.
21Zhu AX,Fuchs CS,Clark JW,et al.A phaseⅡstudy of epirubicin and thalido-mide in unresectable or metastatic hepatocellular carcinoma[J].Oncologist,2005,10(6):392-398.
22Wang B,Xu H,Gao ZQ,et al.Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization[J].Acta Radiol,2008,49(5):523-529.
23Hao MZ,Lin HL,Chen Q,et al.Efficacy of transcatheter arterial chemoemboliza-tion combined thalidomide on he patocellular carcinoma:a controlled randomized trial[J].Ai Zheng,2007,26(8):861-865.
24Goldenberg A,Volm M,Hochster H,et al.Thalidomide(Thal)tolerance in pa-tients treated with transarterial chemoembolization(TACE)for hepatocellular car-cinoma(HCC)[J].Journal of Clinical Oncology,2004ASCO Annual Meeting Proceedings(Post-Meeting Edition).2004,22(14S):4255.
25Hsu WC,Chan SC,Ting LL,.et al.Results of three-dimensional conformal radio-therapy and thalidomide for advanced hepatocellular carcinoma[J].Jpn J Clin ncol,2006,36(2):93-99.
26Hamadani M,Benson DMJr,Copelan EA.Thalidomide-induced fulminant hepatic failure[J].Mayo Clin Proc,2007,82(5):638.
27Lee CC,Wu YH,Chung SH,Chen WJ.Acute Tumor Lysis Syndrome After Tha-lidomide Therapy in Advanced Hepatocellular Carcinoma[J].The Oncologist,2006,11(1):87-88.
28Demeria D,Birchall I,Bain VG.Dramatic reduction in tumour size in hepatocellu-lar carcinoma patients on thalidomide therapy[J].Can J Gastroenterol,2007,21(8):517-518.
29Patt YZ,Hassan MM,Lozano RD,et al.Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide[J].Am J Clin On-col,2000,23(3):319-321. |
